Skip to main content
Register
Log In
Register
Log In
Home
Specialty
Cardiology
Dermatology
Electrophysiology
Family Medicine
Gastroenterology
Immunology
Internal medicine
Managed Markets
Neurology
Ob-Gyn
Oncology
Orthopedic Surgery
Pediatrics
Podiatry
Psychiatry
Pulmonary Medicine
Rheumatology
Urology
Vascular
Wound Care
Events
About us
Specialty
Cardiology
Dermatology
Electrophysiology
Family Medicine
Gastroenterology
Immunology
Internal medicine
Managed Markets
Neurology
Ob-Gyn
Oncology
Orthopedic Surgery
Pediatrics
Podiatry
Psychiatry
Pulmonary Medicine
Rheumatology
Urology
Vascular
Wound Care
Events
About us
Register
Log In
Managed Markets
Filter
Credit Types
Close
Credit Types
All
AANP
AAPA
CME
CNE
CPE
Participation
Latest Courses
Complete
In-Progress
0.50 Credits
Overt Hepatic Encephalopathy: Managed Care Considerations to Optimize Patient Outcomes
Participation
CME
CPE
AAPA
CNE
AANP
Complete
In-Progress
0.25 Credits
Overview and Impact of Overt Hepatic Encephalopathy - Module 1
Participation
CME
CPE
AAPA
CNE
AANP
Complete
In-Progress
0.25 Credits
Pharmacotherapy for Overt Hepatic Encephalopathy - Module 2
Participation
CME
CPE
AAPA
CNE
AANP
Complete
In-Progress
0.25 Credits
Reducing the Burden of Overt Hepatic Encephalopathy - Module 3
Participation
CME
AANP
CNE
CPE
AAPA
Pharmacologic Intervention
View All
Complete
In-Progress
0.25 Credits
Pharmacotherapy for Overt Hepatic Encephalopathy - Module 2
Participation
CME
CPE
AAPA
CNE
AANP
Complete
In-Progress
1.50 Credits
Slowing Cognitive and Functional Decline in Early Alzheimer’s Disease with Amyloid-Beta Targeting Therapies: Considerations for Clinical Pharmacy Professionals
Participation
CME
AAPA
CNE
AANP
CPE
Complete
In-Progress
0.25 Credits
Current and Emerging Management Strategies: A Review of Dietary Recommendations and Pharmaceutical Interventions - Module 3
Participation
CME
CNE
AANP
Complete
In-Progress
1.50 Credits
Slowing Cognitive and Functional Decline in Early Alzheimer’s Disease with Amyloid-Beta Targeting Therapies: Considerations for Clinical Pharmacy Professionals
Participation
CME
CNE
AANP
AAPA
CPE
Complete
In-Progress
1.50 Credits
Slowing Cognitive and Functional Decline in Early Alzheimer’s Disease with Amyloid-Beta Targeting Therapies: Considerations for Managed Care Pharmacy Professionals
Participation
CME
CPE
CNE
AANP
AAPA
All Courses
Complete
In-Progress
0.25 Credits
Overview and Impact of Overt Hepatic Encephalopathy - Module 1
Participation
CME
CPE
AAPA
CNE
AANP
Complete
In-Progress
0.25 Credits
Pharmacotherapy for Overt Hepatic Encephalopathy - Module 2
Participation
CME
CPE
AAPA
CNE
AANP
Complete
In-Progress
0.25 Credits
Reducing the Burden of Overt Hepatic Encephalopathy - Module 3
Participation
CME
AANP
CNE
CPE
AAPA
Complete
In-Progress
0.50 Credits
Overt Hepatic Encephalopathy: Managed Care Considerations to Optimize Patient Outcomes
Participation
CME
CPE
AAPA
CNE
AANP
